Skip to content

Jerash Holdings (US), Inc. JRSH Proceeds From Contributed Capital

Proceeds From Contributed Capital at other companies

Amentum Holdings logo
Amentum HoldingsAMTM
$0-100%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$2.48M
Aebi Schmidt Holding AG Common Stock logo
Aebi Schmidt Holding AG Common StockAEBI
$0-100%
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
$593.5K
Harley-Davidson logo
Harley-DavidsonHOG
$11.65M
WYF
WhiteFiber, Inc. Ordinary SharesWYFI
$0-100%

Other financials

Income statement

See full
Revenue$41.8M+18.0%
Gross profit$7.0M+31.0%
Operating income$1.9M+175%
Net income$1.2M+20,261%
EPS (diluted)$0.09

Balance sheet

See full
Cash & equivalents$11.5M-22.5%
Total debt$365.0K-45.5%
Total equity$63.6M+0.7%
Total assets$84.2M+5.5%

Cash flow

See full
Operating cash flow-$3.8M-26.7%
CapEx$92.0K-35.8%
Free cash flow-$3.9M-23.8%

Valuation

See full
Market cap$61.09M+36.1%
Enterprise value$50M+25.3%
P/E34×-21.1×
P/S0.4×+0.1×

Profitability

See full
Gross margin16.2%+2.7pp
Operating margin2.9%+2.2pp
Net margin1.2%+0.7pp
FCF margin-2.9%

Returns & leverage

See full
Return on equity2.8%+1.7pp
Debt / equity0.0×
Current ratio2.8×-0.3×

Where this comes from

Reported directly by Jerash Holdings (US), Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromContributedCapital.

The official record: Jerash Holdings (US), Inc.’s 10-Q, filed August 14, 2025, on SEC EDGAR. View the filing →

Ask your AI about Jerash Holdings (US), Inc.'s proceeds from contributed capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jerash Holdings (US), Inc.'s proceeds from contributed capital?
Jerash Holdings (US), Inc. (JRSH) reported proceeds from contributed capital of $1.9M in Q2 2025.
What does proceeds from contributed capital mean?
Cash inflows resulting from capital contributions made by shareholders or parent entities. This indicates the level of external financial support or equity infusion provided to the company to fund operations or growth.